GBR830-204
Drug
Ichnos Sciences Inc.
Total Payments
$1.9M
Transactions
614
Doctors
36
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.9M | 614 | 36 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.9M | 614 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| GBR830-204 | Ichnos Sciences Inc. | $1.9M | 36 |
Top Doctors Receiving Payments for GBR830-204
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Allergy | Rolling Hills Estates, CA | $505,913 | 60 |
| , M.D | Research Study | Newport News, VA | $143,266 | 44 |
| , MD | Internal Medicine | Tampa, FL | $142,579 | 5 |
| , M.D | Allergy | Medford, OR | $114,998 | 23 |
| , MD PHD | Dermatology | Webster, TX | $100,184 | 49 |
| , M.D | Internal Medicine | Zephyrhills, FL | $96,187 | 31 |
| , M.D | Allergy | Richmond, VA | $82,575 | 37 |
| , M.D | Dermatology | Fresno, CA | $73,690 | 21 |
| , M.D., PH.D | Dermatology | Newnan, GA | $66,070 | 36 |
| , MD | Pediatrics | Coral Gables, FL | $60,305 | 15 |
| , MD | Dermatology | Spokane, WA | $45,770 | 11 |
| , M.D | Dermatology | Philadelphia, PA | $44,652 | 4 |
| , M.D | MOHS-Micrographic Surgery | Hazleton, PA | $41,287 | 3 |
| , MD | Emergency Medicine | San Antonio, TX | $40,463 | 41 |
| , M.D | Specialist | Birmingham, AL | $37,446 | 6 |
| , MD | Dermatology | Forest Hills, NY | $35,236 | 20 |
| Thomas Ross | — | Lake Worth, FL | $34,084 | 3 |
| , MD | Dermatology | Verona, NJ | $32,859 | 17 |
| , DO MD | Dermatology | Fort Myers, FL | $30,904 | 22 |
| , MD | Family Medicine | Lake City, FL | $26,866 | 40 |
| , MD | Dermatology | Danbury, CT | $23,536 | 22 |
| , M.D | Pediatrics | West Des Moines, IA | $19,119 | 9 |
| , MD | Internal Medicine | Chattanooga, TN | $15,360 | 4 |
| , M.D | Dermatology | Austin, TX | $12,974 | 10 |
| , MD | Dermatology | Plainfield, IN | $12,795 | 1 |
Ad
Manufacturing Companies
- Ichnos Sciences Inc. $1.9M
Product Information
- Type Drug
- Total Payments $1.9M
- Total Doctors 36
- Transactions 614
About GBR830-204
GBR830-204 is a drug associated with $1.9M in payments to 36 healthcare providers, recorded across 614 transactions in the CMS Open Payments database. The primary manufacturer is Ichnos Sciences Inc..
Payment data is available from 2020 to 2020. In 2020, $1.9M was paid across 614 transactions to 36 doctors.
The most common payment nature for GBR830-204 is "Unspecified" ($1.9M, 100.0% of total).
GBR830-204 is associated with 1 research study, including "GBR830-204" ($1.9M).